The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
The impact of non‐motor symptoms on the quality of life of Parkinson's disease patients: a longitudinal study
Abstract
Background and purpose: Non‐motor symptoms (NMS s) are common amongst patients with Parkinson's disease (PD); however, little is known about their influence on the health‐related quality of life (QoL) over a defined follow‐up period. The study was aimed to establish the impact of NMS s on the QoL of patients with PD over a 2‐year follow‐up period. Method: A total of 227 newly referred PD patients were prospectively recruited between 2013 and 2014. The Non‐Motor Symptoms Scale was used to evaluate NMS s burden whilst QoL was assessed with the Parkinson's Disease Questionnaire‐39 items. Motor disabilities were assessed using the Part III (motor) Unified Parkinson's Disease Rating Scale (UPDRS m). Results: The mean age was 64.37 (10.18) years; 59.9% were males and a majority (89.0%) were ethnic Chinese. Almost 65% were unemployed and 84.6% had attained no more than secondary level of education. In the univariate analysis, total NMS s burden, age, gender, subsequent visit, Hoehn and Yahr staging, disease duration and UPDRS m score were individually predictive of change in the Parkinson's Disease Questionnaire Summary Index score from baseline to follow‐up visit. However, in the multivariate analysis, total NMS s burden significantly predicted the QoL scores whilst motor scores did not. Specifically, NMS domains 2 (sleep/fatigue), 3 (mood/apathy) and 5 (attention/memory) were most significantly predictive of QoL change. Conclusion: Unlike motor disabilities, NMS s burden, in particular sleep, mood and attention, have a significant impact on the QoL of PD patients over a 2‐year follow‐up period.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107 · cited 1×
“Parkinson’s disease patients were also assessed for motor disabilities during OFF state using the Part III (motor) Unified Parkinson’s Disease Rating Scale (UPDRSm) [23] and the modified Hoehn and Yahr (H&Y) staging scale [24].”
MethodPeto, V., Jenkinson, C., Fitzpatrick, R., & Greenhall, R. (1995) · Quality of Life Research · doi:10.1007/bf02260863 · Cited by 1,204
Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years
Hely, M. A., Morris, J. G. L., Reid, W. G. J., & Trafficante, R. (2005) · Movement Disorders · doi:10.1002/mds.20324 · Cited by 1,050
Cited by
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs
Charvin, D., Medori, R., Hauser, R. A., & Rascol, O. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.136 · Cited by 287
Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease
Balestrino, R., & Martinez-Martin, P. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.12.060 · Cited by 135
Dlay, J. K., Duncan, G. W., Khoo, T. K., Williams-Gray, C. H., Breen, D. P., Barker, R. A., Burn, D. J., Lawson, R. A., & Yarnall, A. J. (2020) · Brain Sciences · doi:10.3390/brainsci10020078 · Cited by 44
Lacy, B., Piotrowski, H. J., Dewey, R. B., & Husain, M. M. (2023) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2022.100180 · Cited by 27
Leptin levels in patients with Parkinson's disease: A systematic review and meta-analysis
Rahnemayan, S., Mirghafourvand, M., Fathalizadeh, A., Faramarzi, E., Reyhanifard, A., Mahmoodpoor, A., & Sanaie, S. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.11.001 · Cited by 14
Metadata
- Authors
- Prakash, K. M., Nadkarni, N. V., Lye, W. ‐., Yong, M. ‐., & Tan, E. ‐.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2016-01-25
- Volume
- 23
- Issue
- 5
- Pages
- 854-860
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W2272517425
- Cited by
- 229
- References
- 3
- FWCI
- 14.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.